NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes
Following successful FDA Pre-IND meeting, NewcelX advances IND-enabling activities for NCEL-101 Following successful FDA Pre-IND meeting, NewcelX advances IND-enabling activities for NCEL-101